BioNTech

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water (öffnet in neuem Tab)

  Yahoo Finance · 01.10.2026

• Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water (öffnet in neuem Tab)

  24/7 Wall St. · 01.10.2026

• BioNTech SE (BNTX) Stock Price, News, Quote & History (öffnet in neuem Tab)

  Yahoo! Finance Canada · 01.10.2026

• BioNTech SE (BNTX) stock price, news, quote and history (öffnet in neuem Tab)

  Yahoo Finance Australia · 01.10.2026

• Under a June 3 trading plan, BioNTech (BNTX) CEO Ugur Sahin sells 34,000 and 32,000 shares. (öffnet in neuem Tab)

  Stock Titan · 30.09.2026

• Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? (öffnet in neuem Tab)

  Zacks Investment Research · 30.09.2026

• BioNTech to close German manufacturing plants after failing to find buyers (öffnet in neuem Tab)

  BioSpace · 30.09.2026

• Is BioNTech (BNTX) Undervalued As It Closes Vaccine Plants And Restructures? (öffnet in neuem Tab)

  Simply Wall Street · 30.09.2026

• BioNTech(BNTX.US) 10% Shareholder Sells US$6.01 Million in Common Stock (öffnet in neuem Tab)

  Moomoo · 29.09.2026

• Pfizer, BioNTech and Moderna Must Face Bayer Patent Lawsuits Over COVID-19 Vaccines (öffnet in neuem Tab)

  Law Commentary · 29.09.2026

• BioNTech closes four sites after failed sale process as post-COVID vaccine sales slump (öffnet in neuem Tab)

  Manufacturing Chemist · 29.09.2026

• BioNTech to close three sites in Germany after failing to secure a sale (öffnet in neuem Tab)

  Endpoints News · 29.09.2026

• BioNTech to close three German plants after failing to find buyers (öffnet in neuem Tab)

  medwatch.com · 29.09.2026

• BioNTech to close Germany and Singapore sites after sale fails (öffnet in neuem Tab)

  StreetInsider · 29.09.2026

• Can Vaccine Approval Change The Bull Case For BioNTech (BNTX)? (öffnet in neuem Tab)

  Simply Wall Street · 29.09.2026

• Germany news: COVID vaccine maker BioNTech to close 3 sites (öffnet in neuem Tab)

  DW.com · 28.09.2026

• Biontech Insider Sold Shares Worth $6,012,500, According to a Recent SEC Filing (öffnet in neuem Tab)

  marketscreener.com · 28.09.2026

• A trading plan covers BioNTech (BNTX) CEO Ugur Sahin's sales of 27,000 and 34,000 shares. (öffnet in neuem Tab)

  Stock Titan · 28.09.2026

• Pfizer, BioNTech, Moderna dealt blow in effort to dismiss mRNA patent lawsuits (PFE:NYSE) (öffnet in neuem Tab)

  Seeking Alpha · 28.09.2026

• BioNTech to shutter three sites in Germany as no buyers emerge (öffnet in neuem Tab)

  Reuters · 28.09.2026

• Pfizer, BioNTech and Moderna lose bid to dismiss Bayer patent case (öffnet in neuem Tab)

  Investing.com · 28.09.2026

• Covid vaccine -BioNTech shuts down in Germany (öffnet in neuem Tab)

  realnewsmagazine.net · 28.09.2026

• BioNTech to Close 3 German Sites After Unsuccessful Sale Efforts (öffnet in neuem Tab)

  marketscreener.com · 28.09.2026

• Market Chatter: BioNTech to Close 3 German Sites After Unsuccessful Sale Efforts (öffnet in neuem Tab)

  Yahoo Finance · 28.09.2026

• Moderna vs. BioNTech: Which mRNA Cancer Stock Has More Upside? (öffnet in neuem Tab)

  The Globe and Mail · 28.09.2026

• BioNTech to close 3 sites in Germany after failed buyer search (öffnet in neuem Tab)

  Fierce Pharma · 28.09.2026

• BioNTech Plans To Close Unsold German Vaccine Plants (öffnet in neuem Tab)

  Finimize · 28.09.2026

• BioNTech to Close Manufacturing Sites in Germany and Singapore After Sale Process Ends (öffnet in neuem Tab)

  Yahoo Finance · 28.09.2026

• BioNTech to shutter sites in Germany, Singapore as no buyers emerge (öffnet in neuem Tab)

  TradingView · 28.09.2026

• Covid vaccine maker BioNTech to close three sites in Germany (öffnet in neuem Tab)

  Yahoo Finance · 28.09.2026